Patty Harvey

Pleasanton, CA | July 10, 2018: FDAzilla, a global leader in FDA intelligence and analytics, announced the addition of Patty Harvey as Food Product Manager this past February — further filling out its team of industry professionals to include a nationally recognized speaker and food expert.

Patty, raised in Milpitas, CA and currently residing in Vancouver, WA, will provide valuable insights into the food industry as well as focus on developing FDAzilla’s library of food regulatory and enforcement data and analytics tools.

“Patty is a valuable addition to the team as we continue to help Food Manufacturing companies understand the latest FDA trends and to easily monitor their supply chains to reduce risk,” said Michael de la Torre, CEO, FDAzilla. “We are fortunate to have the guidance of someone with her level of expertise as we continually improve our available tools designed to better assist the food industry.”

Patty joins FDAzilla from PL Harvey Consulting, LLC where she continues to consult for the world’s top food companies. She’s excited to show food industry colleagues how to use FDAzilla — what she feels is a key tool in the food safety and regulatory toolbox. A tool that makes her colleagues’ jobs easier, keeps a pulse on suppliers, and shows how the new FSMA/specific regulations are enforced.

“Knowledge is so powerful — it provides insights and drives action. Any tool that instantly transforms data into useful, actionable information is huge — that’s FDAzilla and that’s why I’m excited to join the team,” said Patty.

For more information about Patty, check out her LinkedIn Profile here.

About FDAzilla

FDAzilla is the definitive source for FDA inspection data and analytics — with the world’s most comprehensive FDA inspection database, going back to the year 2000 and covering more than 700,000 inspections at 192,000 sites.

The FDAzilla platform takes this unique, unparalleled data set and provides our customers with the data analytics, benchmarking, monitoring services, and inspection documents they need to make better decisions and stay one step ahead of the FDA.